Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

New African Cassava Resists Devastating Viruses

Published: Tuesday, October 02, 2012
Last Updated: Tuesday, October 02, 2012
Bookmark and Share
Plant scientists at ETH Zurich have developed a new African cassava preferred by consumers and farmers that is resistant to the two major virus diseases in Africa. Now they want to test the resistant cassava in Africa.

Cassava is one of the most important crops in tropical countries, particularly in Sub-Saharan Africa. However, plant viruses are threatening cassava production and with it the staple food of hundreds of millions of people. Under the leadership of Wilhelm Gruissem, Professor of Plant Biotechnology and his senior scientist Dr. Hervé Vanderschuren, researchers at ETH Zurich have used gene technology to develop a new cassava variety that is resistant to the feared cassava brown streak virus. The virus infects the edible starchy roots and turns them brown, which makes the roots unpalatable for consumers. The virus originated in East Africa and is threatening to spread to Central and West Africa.

Developing immune cassava using small RNAs

In order to make cassava resistant to the brown streak virus, the researchers modified the genetic make-up of one variety of cassava to produce small interfering RNA molecules (siRNA). The plant produces the siRNA naturally after virus infection, but the researchers have now tricked cassava to produce the siRNA in all of its parts before the virus can infect it. As soon as the virus attacks the plant, the short siRNA stops the virus by attaching to the genome of the virus that is also made of RNA. This prevents the virus from multiplying and spreading throughout the plant.

Glasshouse trials have shown that the new gene producing the siRNA protects cassava effectively from the virus. Even several months after infection of the transgenic cassava plants with the brown streak virus, the scientists did not find any evidence that the virus could multiply. The production of the siRNA does not affect cassava itself. It grows normally and produces healthy roots. The researchers targeted a part of the virus RNA genome that has been highly conserved during evolution and thus only very rarely changes. This should make it more difficult for the virus to adapt to the siRNA-mediated immunity.

Resistance to another cassava virus remains

The researchers used the Nigerian TME 7 variety, also known as “Oko-iyawo”. This variety is naturally resistant to cassava mosaic disease, which is caused by another virus that is severely impacting cassava production all of Africa. Prof. Wilhelm Gruissem explains that this resistance is not changed by the new resistance to the brown streak virus. The brown streak virus is most likely transmitted by the same silverleaf whitefly (Latin: Bemisia tabaci) that also spreads cassava mosaic disease. This tiny insect sucks on plant juices, and in doing so transmits the viruses into the cassava plant. The silverleaf whitefly population has hugely increased in recent decades, emphasises Prof. Willhelm Gruissem, and is posing a greater threat than ever to the growth of cassava. He adds that it is difficult to control the whitefly, even if African farmers can afford to buy insecticides. This is why it is much more efficient and more environmentally friendly to protect cassava against viruses using genetic modification.

Preferred variety extended

The ETH Zurich scientists chose TME 7 from dozens of potential varieties because TME 7 is popular among consumers and farmers and has the best prerequisites for successful cultivation. As the next step, Prof. Gruissem and Dr. Vanderschuren, together with colleagues in Africa, want to test if the improved cassava variety in the field remains resistant to both viruses under natural conditions. The Fiat Panis Foundation in Germany, which has supported cassava research at ETH, has already reserved funding for field experiments. The ETH Zurich scientists are also actively engaged in transferring the technology to interested research institutes in Africa to develop virus resistance in local varieties preferred by consumers in their countries.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Tuesday, November 03, 2015
Bumblebee Genome Mapped
A research collaboration spearheaded by ETH Zurich has shed light on the genome of two commercially important species of bumblebees. The findings provide unexpected insights into the ecology and evolution of bumblebees and honeybees.
Thursday, April 30, 2015
Controlling Genes with Your Thoughts
Researchers develop the first gene network to be operated via brainwaves.
Tuesday, November 11, 2014
New Defence Mechanism Against Viruses Discovered
Mechanism may represent one of the oldest defence mechanisms against viruses in evolutionary history.
Friday, September 12, 2014
Protecting Olive Oil from Counterfeiters
Using magnetic DNA particles, ETH Zurich researchers have shown how olive oil can be tagged to prevent counterfeiting.
Friday, April 25, 2014
Swiss researchers develop rice with increased (six-fold!) iron content
Scientists at ETH Zurich have developed rice plants that contain six times more iron in polished rice kernels.
Thursday, August 20, 2009
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos